Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 339

    1.

    Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

    Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB.

    Ann Intern Med. 1996 Dec 1;125(11):873-82.PMID: 8967667 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

    Waters D, Danska J, Hardy K, Koster F, Qualls C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D.

    Ann Intern Med. 1996 Dec 1;125(11):865-72.PMID: 8967666 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

    Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.

    Ann Intern Med. 1998 Jul 1;129(1):18-26.PMID: 9652995 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy.

    Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'brien F, Svanberg E; Serono 9037 Study Team.

    J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):367-75.PMID: 15097153 [PubMed - indexed for MEDLINE]Related articles

    5.

    A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.

    Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S.

    J Clin Endocrinol Metab. 2005 Aug;90(8):4474-82. Epub 2005 May 24.PMID: 15914526 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.

    Hengge UR, Stocks K, Wiehler H, Faulkner S, Esser S, Lorenz C, Jentzen W, Hengge D, Goos M, Dudley RE, Ringham G.

    AIDS. 2003 Mar 28;17(5):699-710.PMID: 12646793 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.

    Rodríguez-Arnao J, Jabbar A, Fulcher K, Besser GM, Ross RJ.

    Clin Endocrinol (Oxf). 1999 Jul;51(1):53-60.PMID: 10468965 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.

    Mulligan K, Zackin R, Clark RA, Alston-Smith B, Liu T, Sattler FR, Delvers TB, Currier JS; AIDS Clinical Trials Group 329 Study Team; National Institute of Allergy and Infectious Diseases Adult AIDS Clinical Trials Group.

    Arch Intern Med. 2005 Mar 14;165(5):578-85.PMID: 15767536 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.

    Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein MK.

    JAMA. 1999 Apr 14;281(14):1282-90.PMID: 10208143 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.

    Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G.

    J Clin Endocrinol Metab. 1998 Sep;83(9):3155-62.PMID: 9745419 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.

    Hengge UR, Stocks K, Faulkner S, Wiehler H, Lorenz C, Jentzen W, Hengge D, Ringham G.

    HIV Clin Trials. 2003 May-Jun;4(3):150-63.PMID: 12815555 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

    Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.

    J Clin Endocrinol Metab. 1996 Nov;81(11):4051-8.PMID: 8923860 [PubMed - indexed for MEDLINE]Related articles

    14.

    Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.

    Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon S.

    J Clin Endocrinol Metab. 1998 Aug;83(8):2717-25.PMID: 9709937 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.

    Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, Hubbard J, Anderson EJ, Basgoz N, Heller HM, Klibanski A.

    J Clin Endocrinol Metab. 1997 May;82(5):1332-7. Erratum in: J Clin Endocrinol Metab 1997 Oct;82(10):3360. PMID: 9141512 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.

    Hansen TB, Gram J, Jensen PB, Kristiansen JH, Ekelund B, Christiansen JS, Pedersen FB.

    Clin Nephrol. 2000 Feb;53(2):99-107.PMID: 10711411 [PubMed - indexed for MEDLINE]Related articles

    17.

    The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

    Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D.

    J Clin Endocrinol Metab. 1998 Jan;83(1):107-16.PMID: 9435425 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

    Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO.

    Ann Intern Med. 2008 Nov 4;149(9):601-11.PMID: 18981485 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.

    Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A.

    Ann Intern Med. 1996 Dec 1;125(11):883-90.PMID: 8967668 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data